Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025

Reuters

2025/08/29

Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025

Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Group remains focused on providing hospital, rehabilitation, haemodialysis, and elderly healthcare services in the PRC.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong Kanghua Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2563017641"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2563017641\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2563017641?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 16:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2563017641","market":"us","top_or_hot":-1,"title":"Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Group remains focused on providing hospital, rehabilitation, haemodialysis, and elderly healthcare services in the PRC.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong Kanghua Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-29 16:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Group remains focused on providing hospital, rehabilitation, haemodialysis, and elderly healthcare services in the PRC.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong Kanghua Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03689","symbol_name":"康华医疗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDL70xTHc:1","article_id":"2563017641","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2563017641","pubTimestamp":1756456549,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Gro","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"03689":"康华医疗"},"translate_title":"广东康华医疗报告2025年上半年收入下降0.3%，利润降至人民币32.6百万元，每股收益为人民币12.5分","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03689":0.9},"content_text":"Guangdong Kanghua Healthcare Reports 0.3% Dip in Revenue, Swings to RMB32.6 Million Profit, EPS at RMB12.5 Cents for H1 2025\n    \n\n        Guangdong Kanghua Healthcare Group Co. Ltd. has announced its unaudited condensed consolidated interim results for the six months ended 30 June 2025. The company reported a slight decrease in revenue by 0.3%, amounting to RMB981.5 million compared to RMB984.5 million for the same period in 2024. Profit for the reporting period rose to RMB32.6 million, a significant turnaround from a loss of RMB24.7 million in the previous year. Profit attributable to the owners of the company increased to RMB41.6 million, contrasting with a loss of RMB19.5 million for the corresponding period in 2024. Adjusted EBITDA saw a substantial increase of 38.7%, reaching RMB126.7 million, up from RMB91.3 million in the previous year. Earnings per share were reported at RMB12.5 cents, improving from a loss per share of RMB5.8 cents in the prior year. The Board does not recommend the payment of an interim dividend for the period ended 30 June 2025, consistent with the decision for the same period in 2024. The Group remains focused on providing hospital, rehabilitation, haemodialysis, and elderly healthcare services in the PRC.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong Kanghua Healthcare Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}